Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 27:9:7.
doi: 10.1186/1476-511X-9-7.

A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies

Angela M Rizzo  1 , Gigliola Montorfano, Manuela Negroni, Laura Adorni, Patrizia Berselli, Paola Corsetto, Klaus Wahle, Bruno Berra
Affiliations

A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies

Angela M Rizzo et al. Lipids Health Dis. .

Abstract

Background: Omega-3 and -6 polyunsaturated fatty acids (LCPUFA), are important for good health conditions. They are present in membrane phospholipids.The ratio of total n-6:n-3 LCPUFA and arachidonic acid:eicosapentaenoic acid (AA and EPA), should not exceed 5:1. Increased intake of n-6 and decreased consumption of n-3 has resulted in much higher, ca 10/15:1 ratio in RBC fatty acids with the possible appearance of a pathological "scenario". The determination of RBC phospholipid LCPUFA contents and ratios is the method of choice for assessing fatty acid status but it is labour intensive and time consuming.

Aims of the study: [i] To describe and validate a rapid method, suitable for large scale population studies, for total blood fatty acid assay; [ii] to verify a possible correlation between total n-6:n-3 ratio and AA:EPA ratios in RBC phospholipids and in whole-blood total lipids, [iii] to assess usefulness of these ratio as biomarkers of LCPUFA status.

Methods: 1 Healthy volunteers and patients with various pathologies were recruited.2 Fatty acid analyses by GC of methyl esters from directly derivatized whole blood total lipids and from RBC phospholipids were performed on fasting blood samples from 1432 subjects categorised according to their age, sex and any existing pathologies.AA:EPA ratio and the total n-6:n-3 ratio were determined.

Results: AA:EPA ratio is a more sensitive and reliable index for determining changes in total blood fatty acid and it is correlated with the ratio derived from extracted RBC phospholipids.

Conclusions: The described AA:EPA ratio is a simple, rapid and reliable method for determining n-3 fatty acid status.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of the linear correlations between the total omega-6/omega-3 ratios (A) and the AA/EPA ratios (B) in whole blood and in RBC membrane.
Figure 2
Figure 2
The AA/EPA and total omega-6/omega-3 ratios in whole blood of healthy subjects not using fish oil supplements and grouped by age. Mean ± S.E; Student's t-test: * p < 0.05 vs 0-20; § p < 0.05 vs 21-40; §§ p < 0.01 vs 21-40, number of subjects as in table 1.
Figure 3
Figure 3
AA/EPA and omega-6/omega-3 ratios in whole blood of healthy subjects and in a group of patients with various pathologies, with and without consumption of omega-3. Mean ± S.E; Student's t-test: ## p < 0.01 with omega-3 vs without omega-3; ** p < 0.01 pathological vs healthy; number of subjects as in Table 1.
Figure 4
Figure 4
(A) AA/EPA ratios and (B) omega-6/omega-3 ratios in whole blood of patients grouped according to their specific pathologies. The horizontal lines indicate the mean value for all the healthy subjects that do not use omega-3.
See this image and copyright information in PMC

References

    1. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio. and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60:502–507. doi: 10.1016/j.biopha.2006.07.080. - DOI - PubMed
    1. Berge JP, Barnathan G. Fatty acids from lipids of marine organisms: molecular biodiversity, roles as biomarkers, biologically active compounds, and economical aspects. [Review] Advances in Biochemical Engineering- Biotechnology. 2005;96:49–125. - PubMed
    1. INRAN: Linee guida per una sana alimentazione italiana. Internet. 2003;27 http://www.inran.it
    1. Schwab J, Serhan CN. Lipoxine and new lipid mediators in the resolution of inflammation. Curr Opin Pharmacol. 2006;6:414–420. doi: 10.1016/j.coph.2006.02.006. - DOI - PubMed
    1. Whelan J. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. J Nutr. 1996;126:1086S–1091S. - PubMed

Publication types